Patent details

Basic Information

Publication number:

EP3583953

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP191765890

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

German

English Title of Invention:

OPTIMISED INJECTION FORMULATION FOR MRNA

French Title of Invention:

FORMULE DÍNJECTION OPTIMISÉE POUR ARNM

German Title of Invention:

OPTIMIERTE INJEKTIONSLÖSUNG FÜR MRNA

SPC Number:

Dates

Filing date:

19/05/2006

Grant date:

28/06/2023

EP Publication Date:

25/12/2019

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

28/06/2023

EP B1 Publication Date:

28/06/2023

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

19/05/2024

Expiration date:

19/05/2026

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

21/06/2023

 

 

Name:

CureVac SE

Address:

Friedrich-Miescher-Straße 15, 72076 Tübingen, Germany (DE)

Inventor

1

Name:

HOERR, Ingmar

Address:

Germany (DE)

2

Name:

PASCOLO, Steve

Address:

Germany (DE)

Priority

Priority Number:

102005023170

Priority Date:

19/05/2005

Priority Country:

Germany (DE)

Classification

IPC classification:

A61K 47/02; A61K 47/12; A61K 9/00; A61K 31/7088; C12N 15/87; A61K 48/00;

Publication

European Patent Bulletin

Issue number:

202326

Publication date:

28/06/2023

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages